alnylam pharmaceuticals glp-1 receptor agonist Agonists as Treatments for Type 2 Diabetes Emerging Frontiers in GLP-1 Therapeutics:

Some Medicare patients will be able to access GLP-1 medication for weight loss for the first time starting July 1, paying a $50 monthly copay through a new program designed to make the drugs more...

To help people figure out who qualifies, whats involved and what to expect for first-time GLP-1 users, a pair of weight management specialists at MUSC Health sat down for this Q&A.

Some people who take GLP-1 drugs such as semaglutide and tirzepatide see little to no changes to their weight

A new case series presents a unique paradox where GLP-1 RA therapy improved quality of life and resolved diarrhea in two women with

Your workforce likely has a growing interest (or curiosity) in GLP-1 medications

Tirzepatide is a new drug targeting glucagon-like peptide 1(GLP1) and gastric inhibitory polypeptide (GIP) receptors